Global Anti-Clot Drugs Industry to 2027 – by Type, Application, Distribution Channel and Region –


DUBLIN–(BUSINESS WIRE)–The “Anti-Clot Drugs Market – Global Industry Size, Share, Trends, Opportunities and Forecast 2017 – 2027” report has been added to from offer.

The global anti-clot drugs market is expected to grow at a significant CAGR during the forecast period 2023-2027. The growth of the market can be attributed to the rising incidence of cardiovascular diseases and increasing demand for effective pharmaceuticals for the immediate response to strokes.

Anti-clot medications are heart disease medications that help dissolve blood clots caused by blocked veins, a common cause of strokes and heart attacks. Anti-clot drugs, also known as thrombolytic therapies, are heart medications frequently given under medical supervision in hospitals by intravenous injection. The use of these drugs helps prevent persistent heart damage during a heart attack or deterioration due to an ischemic stroke.

Over the next five years, the global anti-clot drugs market is expected to grow due to an increase in the prevalence of cardiovascular diseases such as heart attacks and strokes. Stroke is the fifth most common cause of death in the United States. The increasing number of strokes requires an immediate response to the situation, where clot-busting medications can help by dissolving the blood clot that builds up in the veins, causing blood pressure to drop.

The mortality rate of the population is increasing due to strokes, fueling the growth of the global anti-clot drugs market. Additionally, increasing risk of ischemic stroke in the global population is expected to support the growth of the global anti-clot drug market over the next five years.

Years considered for this report:

  • Historical years: 2017-2020

  • Base year: 2021

  • Estimated year: 2022

  • Forecast period: 2023-2027

Goal of the study:

  • To analyze the historical growth of the global anti-clot drugs market size from 2017 to 2021.

  • Estimate and forecast the global Anti-Clot Drugs market size from 2023 to 2027 and the growth rate till 2027.

  • To classify and forecast the global anti-clot drugs market based on type, application, distribution channel, region, and company.

  • To identify the dominant region or segment in the global Anti-Clot Drugs market.

  • Identify drivers and challenges in the Global Anti-Clot Drugs Market.

  • Examine competitive developments such as expansions, new product launches, mergers and acquisitions, etc., in the global Anti-Clot Drugs Market.

  • To identify and analyze the profiles of key players operating in the global Anti-Clot Drugs Market.

  • To identify the key sustainable strategies adopted by market players in the global Anti-Clot Drugs Market.

Companies cited

  • F. Hoffmann-La Roche SA

  • Taj Pharmaceuticals Limited

  • Eumedica Pharmaceuticals SA

  • SEDICO Pharmaceutical Company

  • Mochida Pharmaceutical Co.,Ltd

  • Medac GmbH

  • Microbix Biosystems Inc

  • Crinos SpA

Report Scope:

In this report, the global anti-clot drugs market has been segmented into the following categories, in addition to industry trends which have also been detailed below:

Anti-Clot Drugs Market, By Type:

  • Fibrin-specific drugs

  • Tissue plasminogen activator

  • Replace

  • Tenecteplase

  • Others

  • Non-fibrin-specific drugs

  • Urokinase

  • Streptokinase

  • Plasminogen activator complex

Anti-Clot Drugs Market, By Application:

  • Myocardial infarction

  • Pulmonary embolism

  • Deep vein thrombosis

  • Acute ischemic stroke

  • Others

Anti-Clot Drugs Market, By Distribution Channel:

  • Retail pharmacies

  • Hospital pharmacies

  • Online pharmacies

Clot Buster Drugs Market, By Region:

  • North America

  • United States

  • Mexico

  • Canada

  • Europe

  • France

  • Germany

  • UK

  • Italy

  • Spain

  • Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Australia

  • Middle East and Africa

  • South Africa

  • Saudi Arabia

  • United Arab Emirates

  • Egypt

  • South America

  • Brazil

  • Argentina

  • Colombia

For more information on this report, visit


Comments are closed.